Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 7/20 | 0.63 |
| ▸ | HTR6 | P50406 | 2/20 | 0.59 |
| ▸ | HTR1A | P08908 | 6/20 | 0.58 |
| ▸ | HTR2C | P28335 | 4/20 | 0.58 |
| ▸ | HTR2B | P41595 | 4/20 | 0.58 |
| ▸ | HTR1B | P28222 | 5/20 | 0.52 |
| ▸ | HTR1D | P28221 | 5/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | HTR1E | P28566 | 1/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.52 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.52 |
| ▸ | HTR7 | P34969 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | HTR5A | P47898 | 1/20 | 0.52 |
| ▸ | HTR1F | P30939 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26646464 | 0.97 | HTR2A (0.65) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL26307597 | 0.96 | HTR2A (0.66) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL25790561 | 0.95 | HTR6 (0.62) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL31404490 | 0.94 | HTR6 (0.61) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL26323233 | 0.94 | HTR6 (0.61) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL31404488 | 0.90 | HTR6 (0.62) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL25074574 | 0.89 | HTR6 (0.64) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL30637142 | 0.89 | HTR6 (0.64) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL31024345 | 0.89 | HTR6 (0.56) | HTR2AHTR6HTR1AHTR2CHTR2B | |
| SCHEMBL26307748 | 0.89 | HTR6 (0.56) | HTR2AHTR6HTR1AHTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295086-A1 | NOVEL PSILOCIN DERIVATIVES HAVING PRODRUG PROPERTIES | HERCULES CAPITAL, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230295086-A1 | NOVEL PSILOCIN DERIVATIVES HAVING PRODRUG PROPERTIES | HERCULES CAPITAL, INC. | 2023-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295086-A1 | NOVEL PSILOCIN DERIVATIVES HAVING PRODRUG PROPERTIES | HTR2A, HTR2C, HTR5A | HTR2A 1/4885HTR6 8/4885HTR1A 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.